Dividend reinvestment plans, or DRIPs, can be effective ways to accumulate shares of high-quality companies for those with limited capital to invest. Often times, investors can buy fractional shares of companies for as little as $25 a transaction. Many companies offer ways to acquire shares of their business without a fee, allowing the investor to
Month: April 2022
Shares of GameStop (GME) are falling again following a March rally. Some investors may be considering buying GME stock ahead of a planned stock split. Be careful, as market conditions are not in GameStop’s favor. Source: Shutterstock Following months of steady declines, GameStop (NYSE:GME) “Apes” received some relief in March. A short-lived rally in “risk-on”
Crown Castle International (NYSE:CCI – Get Rating) updated its FY 2022 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $7.310-$7.410 for the period. The company issued revenue guidance of -. CCI has been the subject of several recent research reports. Bank of America lifted their price target on Crown Castle
All eyes will be on the FAANG stocks in the next 2 weeks but can they keep their momentum or will they disappoint? Visit our website: https://www.zacks.com Visit our Stocktwits account: https://stocktwits.com/ZacksResearch Check out our weekly promotion: https://www.zacks.com/promo If you’re interested in our services, please check out Zacks Ultimate: https://www.zacks.com/ultimate/?adid=YOUTUBE&cid=sm-YOUTUBE
Fans gather at the Netflix booth at a trade show. Mike Blake | Reuters Check out the companies making headlines after the bell: Netflix — Shares of the streaming giant plummeted 25% after reporting a loss of 200,000 subscribers in the first quarter. It marked the first time Netflix reported a loss in subscribers in
The cannabis sector, which has been responsible for therapeutic and recreational highs across millenniums, have contributed to devastating lows for many investors. Truth be told, that goes for Canada’s OrganiGram (NASDAQ:OGI), which is quite possibly the best pot stock to pick up now for long-term gains. True, OGI is down over 8% year-to-date and is
Excitement stemming from possible U.S. pot reform has dissipated and Canopy Growth (CGC) stock is again moving lower. While better positioned to capitalize on pot reform than peers, other issues will likely push it to lower prices. Much like how you should “just say no” to Hexo (HEXO), the same applies here with Canopy. Source:
The Southern Company (NYSE:SO – Get Rating) has been given an average recommendation of “Hold” by the twelve research firms that are covering the stock, MarketBeat reports. One analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and five have issued a buy recommendation on the company. The average
Gold House Gold House Megan Ruan knows firsthand how representation can impact funding for entrepreneurs. She recalled being the only woman of color working at a family office earlier in her career and running a portfolio of venture investments. “I saw the decisionmaking and how it differed between the people that were check-writers at these
Vials labelled “COVID-19 Coronavirus Vaccine” and syringe are seen in front of displayed Johnson & Johnson logo in this illustration taken, February 9, 2021. Dado Ruvic | Reuters Check out the companies making headlines in midday trading Tuesday. Johnson & Johnson — Shares of the pharmaceutical and consumer giant gained 3% after the company beat
Home Depot (NYSE:HD) stock has been under pressure since the start of the year. The general economic downturn coupled with the company’s earnings and outlook has pressured HD stock and investors are looking for a way out. Shares of the home retailer are down 26% since the start of the year. It comes as a
Food delivery specialist DoorDash (NYSE:DASH) is feeling the heat as people return to pre-pandemic activities. To control costs, DASH stock announced it would be stepping off the gas with its hiring this year, growing headcount by just 10% to 15%. DoorDash’s employee count increased by more than 50% to over 8,600 last year. The company’s
Shares of Cryoport, Inc. (NASDAQ:CYRX – Get Rating) have received a consensus rating of “Buy” from the eight research firms that are currently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation and five have given a buy recommendation to the company. The average 12 month price
In this article MS In this photo illustration, the Twitter logo is displayed on the screen of an iPhone in front of a computer screen displaying Twitter logos. Chesnot | Getty Images Check out the companies making headlines in midday trading. Twitter — Shares rose 3.4% after Twitter announced Friday that the board adopted a
Ameresco (AMRC): The clean technology integrator now offers utility-scale battery storage solutions and boasts a large backlog. ON Semiconductor (ON): Growing demand for electric vehicles and business automation have boosted top line growth. Plug Power (PLUG): Hydrogen fuel cell manufacturer anticipates a 80% increase in revenue this year. Source: Shutterstock As the demand for solar,
Franklin Resources (BEN): Asset management giant with a forward yield of 4.41%. First Interstate Bancsystem (FIBK): Under-the-radar banking play with a 4.76% dividend yield. It could see big earnings growth next year. Leggett & Platt (LEG): Hit hard in the past year, despite a 50-year track record of raising its annual dividend. LyondellBasell Industries (LYB): A
AMC Entertainment (NYSE:AMC) recently announced that it acquired seven locations with 66 screens in Connecticut, Upstate New York and Annapolis, Maryland. The meme-friendly theatre chain acquired the theatres from Bow Tie Cinemas. AMC stock gained 6% on the news. While the stock got a one-day boost from the news, the acquisition of these theatres will
Cortexyme (NASDAQ:CRTX – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Monday, Zacks.com reports. According to Zacks, “Cortexyme Inc. is a clinical-stage biopharmaceutical company. It is focused on providing disease-modifying therapeutics to treat Alzheimer’s and other degenerative diseases. The company’s drug
Definitive Healthcare (NASDAQ:DH – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report issued on Monday, Zacks.com reports. According to Zacks, “Definitive Healthcare Corp. provides healthcare commercial intelligence. The company’s SaaS platform creates new paths in the healthcare market. Definitive Healthcare Corp. is based in
Caterpillar (CAT): The heavy equipment manufacturer is enjoying rising demand from miners and energy companies fueled by increased capital spending. Exxon Mobil (XOM): The energy giant is offering stability through diversified operations as well as upside potential due to rising oil prices. Trade Desk (TTD): The digital ad platform saw a 47% increase in gross spend last
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 13
- Next Page »